LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

Fulgent Genetics Inc

Gesloten

SectorGezondheidszorg

21.26 -2.25

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

21.14

Max

21.31

Belangrijke statistieken

By Trading Economics

Inkomsten

-7.4M

-19M

Verkoop

8.3M

82M

Winstmarge

-23.539

Werknemers

1,313

EBITDA

-3.5M

-15M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+14.68% upside

Dividenden

By Dow Jones

Volgende Winsten

7 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

82M

631M

Vorige openingsprijs

23.51

Vorige sluitingsprijs

21.26

Nieuwssentiment

By Acuity

50%

50%

157 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Fulgent Genetics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 aug 2025, 16:11 UTC

Belangrijke Marktbewegers

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

15 aug 2025, 22:22 UTC

Marktinformatie

Global Equities Roundup: Market Talk

15 aug 2025, 22:22 UTC

Marktinformatie

Target Is Falling Behind Its Peers -- Market Talk

15 aug 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

15 aug 2025, 20:33 UTC

Marktinformatie

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

15 aug 2025, 20:25 UTC

Winsten
Acquisities, Fusies, Overnames

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

15 aug 2025, 20:24 UTC

Winsten
Acquisities, Fusies, Overnames

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 aug 2025, 20:18 UTC

Winsten

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 aug 2025, 19:14 UTC

Marktinformatie

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

15 aug 2025, 19:12 UTC

Marktinformatie

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

15 aug 2025, 18:32 UTC

Marktinformatie

Coffee Futures Surge on New Brazilian Frost -- Market Talk

15 aug 2025, 17:33 UTC

Marktinformatie

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

15 aug 2025, 17:23 UTC

Marktinformatie
Winsten

Deere's Earnings Appear to Be Troughing -- Market Talk

15 aug 2025, 16:27 UTC

Winsten

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

15 aug 2025, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

15 aug 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

15 aug 2025, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

15 aug 2025, 16:05 UTC

Acquisities, Fusies, Overnames

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

15 aug 2025, 15:52 UTC

Acquisities, Fusies, Overnames

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

15 aug 2025, 15:36 UTC

Marktinformatie

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

15 aug 2025, 15:29 UTC

Winsten

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 aug 2025, 15:29 UTC

Acquisities, Fusies, Overnames

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 aug 2025, 15:28 UTC

Winsten

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

15 aug 2025, 15:24 UTC

Marktinformatie

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

15 aug 2025, 15:08 UTC

Marktinformatie

Applied Materials Is Losing Share in Chips Business -- Market Talk

15 aug 2025, 14:38 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

15 aug 2025, 14:37 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

15 aug 2025, 14:37 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

15 aug 2025, 14:36 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

15 aug 2025, 14:33 UTC

Acquisities, Fusies, Overnames

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

Peer Vergelijking

Prijswijziging

Fulgent Genetics Inc Prognose

Koersdoel

By TipRanks

14.68% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 24.38 USD  14.68%

Hoogste 30 USD

Laagste 21 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fulgent Genetics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technische score

By Trading Central

17.32 / 19.04Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Neutral Evidence

Sentiment

By Acuity

157 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.